Detalles de la búsqueda
1.
First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies.
Invest New Drugs
; 40(3): 586-595, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113285
2.
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 4(4): e175245, 2018 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29423521
3.
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.
J Clin Oncol
; 23(22): 5044-51, 2005 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15955901
Resultados
1 -
3
de 3
1
Próxima >
>>